Hospital discharge using salbutamol as required after acute attacks of wheeze in children: a service evaluation

Gary Connett1, Stephanie Harper2, Bhargav Raut3

  • 1Paediatric Respiratory Medicine, University Hospital Southampton NHS Fundation Trust, Southampton, Hampshire, UK gary.connett@uhs.nhs.uk.

PubMed

Insights

UK hospitals can safely reduce salbutamol (asthma medication) for children with acute wheeze. New guidance allows parents to administer bronchodilators as needed, significantly lowering medication use and improving care.

Area of Science:

  • Pediatrics
  • Respiratory Medicine
  • Pharmacology

Background:

  • Standard UK hospital practice involves discharging children with acute wheeze on a fixed-dose salbutamol (bronchodilator) weaning regimen.
  • This approach may lead to overuse of medication and suboptimal management strategies.

Purpose of the Study:

  • To evaluate the safety and efficacy of a new practice: administering bronchodilators only as needed (PRN) after 4-hourly assessments for children post-acute wheeze hospitalization.
  • To compare this PRN approach with traditional fixed-dose weaning regimes.

Main Methods:

  • A multidisciplinary team collaborated with eight families to develop PRN salbutamol guidance for children after hospital treatment for acute wheeze.
  • Data on salbutamol usage and reattendance rates were collected and compared to the previous year's cohort using fixed-dose weaning.

Main Results:

  • 103 families participated, showing significant reductions in salbutamol use: 73% on day 1, 69% on day 2, and 50% on day 3 compared to the previous regime.
  • Families found the PRN advice easy to follow, and there was a trend towards lower reattendance rates within one week.
  • Parents who had previously experienced the fixed-dose regime preferred the new PRN approach.

Conclusions:

  • Providing information to support as-needed salbutamol use enables parents to safely manage children with acute wheeze at home.
  • This PRN strategy results in significantly lower doses of salbutamol compared to standard fixed-dose weaning regimens.
  • The findings support a shift in clinical practice towards PRN bronchodilator use for children recovering from acute wheeze.
Abstract

Related Concept Videos

Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
278
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
287
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.6K
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
818
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
300